Quadrant Biosciences Overview

  • Founded
  • 2012
  • Status
  • Private
  • Employees
  • 57
  • Latest Deal Type
  • Crowdfunding
  • Latest Deal Amount
  • $1.43M
Latest Deal Amount
  • Investors
  • 3

Quadrant Biosciences General Information


Developer of medical screening device designed to provide epigenetic diagnostic services. The company's device is involved in exploring and developing novel biomarker technologies with a focus on Autism Spectrum Disorder, concussion and Parkinson's Disease, enabling the healthcare industry to treat patients with autism through early diagnosis.

Contact Information

Formerly Known As
Motion Intelligence
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Primary Office
  • 505 Irving Avenue
  • Suite 3100 AB
  • Syracuse, NY 13210
  • United States
+1 (315) 000-0000

Quadrant Biosciences Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Quadrant Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Equity Crowdfunding 15-Aug-2020 $1.43M 000.00 Completed Generating Revenue
9. Later Stage VC 23-Jan-2020 00.00 000.00 Completed Generating Revenue
8. Later Stage VC 01-Jan-2020 0000 000.00 Completed Generating Revenue
7. Later Stage VC 27-Jun-2019 00000 00.000 Completed Generating Revenue
6. Grant 19-Jun-2019 00000 00.000 Completed Generating Revenue
5. Grant 19-Sep-2018 00.000 00.000 Completed Generating Revenue
4. Debt - General 01-Mar-2018 00.000 Completed Generating Revenue
3. Early Stage VC (Series A) 13-Dec-2016 00.000 00.000 000.00 Completed Startup
2. Grant 01-Jan-2016 $225K Completed Startup
1. Grant 31-May-2013 $25K Completed Startup
To view Quadrant Biosciences’s complete valuation and funding history, request access »

Quadrant Biosciences Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00 00 00 00.000
To view Quadrant Biosciences’s complete cap table history, request access »

Quadrant Biosciences Executive Team (13)

Name Title Board Seat Contact Info
Richard Uhlig Founder, Chief Executive Officer & Chairman
Benjamin Perry President
Richard Bongo Chief Financial Officer & Board Member
Bryan Greene Chief Operating Officer
David MacLean JD Chief Marketing Officer
You’re viewing 5 of 13 executive team members. Get the full list »

Quadrant Biosciences Board Members (8)

Name Representing Role Since
Andrew Rock Self Board Member 000 0000
Ira Fedder MD Self Board Member 000 0000
James Croke JD Quadrant Biosciences General Counsel & Board Member 000 0000
Mary Tyszko Self Board Member 000 0000
Peter Cohen Quadrant Biosciences Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Quadrant Biosciences Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quadrant Biosciences Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Pearl Gray Equity Partners Impact Investing Minority 000 0000 000000 0
National Institutes of Health Government Minority 000 0000 000000 0
CenterState CEO Government 000 0000 000000 0
To view Quadrant Biosciences’s complete investors history, request access »